ArticlePloS one2025
Enhanced machine learning and hybrid ensemble approaches for Coronary Heart Disease prediction.
Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Development and validation of an explainable web-based machine learning model for predicting early postoperative hypocalcemia in patients with differentiated thyroid cancer.Gland surgery · 2026Article
- Leakage-Safe Precision-Aware Dual-Branch FT-Transformer for Population-Scale Heart Disease Risk Prediction.Sensors (Basel, Switzerland) · 2026Article
- Deep Learning-Assisted Early Detection of Skin Cancer from Dermoscopic Images in Underserved Clinical Settings.Bioengineering (Basel, Switzerland) · 2026Article
- Artificial intelligence in neurocardiology: decoding brain-heart network interactions for clinical and translational insights.Frontiers in neuroscience · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Coronary heart disease (CHD) remains the leading cause of mortality worldwide, disproportionately affecting low- and middle-income countries where diagnostic resources are limited. Traditional statistical models often fail to deliver adequate predictive accuracy in complex, high-dimensional, and imbalanced health datasets. To develop and evaluate enhanced machine learning and hybrid ensemble models for the prediction of coronary heart disease, with a focus on improving diagnostic performance, interpretability, and applicability in resource-constrained settings. We utilized a nationally representative dataset of 253,680 individuals from the Behavioral Risk Factor Surveillance System. Preprocessing included normalization and balancing via the Synthetic Minority Oversampling Technique (SMOTE). Baseline models-Decision Trees, Random Forests, Gradient Boosting, and Support Vector Machines-were compared against improved versions: Adaptive Noise-Resistant Decision Tree (ADNRT), Hybrid Imbalanced Random Forest (HIRF), Pruned Gradient Boosting Machine (PGBM), and Enhanced Support Vector Machine (ESVM). Ensemble approaches (stacking, boosting, bagging, Bayesian model averaging and majority voting) were implemented and evaluated using accuracy, sensitivity, specificity, and area under the curve (AUC). Calibration and learning curves were also analyzed. Enhanced models consistently outperformed their baseline counterparts. PGBM achieved the highest sensitivity (90.8%), while HIRF demonstrated the best overall calibration and balance (AUC = 0.937; sensitivity = 88.4%; specificity = 82.9%). The stacking ensemble emerged as the best-performing model with an accuracy of 87.2%, sensitivity of 89.6%, specificity of 84.7%, and AUC of 0.94. Calibration and learning curve analyses confirmed strong generalizability and low overfitting across ensemble models. Hybrid ensemble machine learning models significantly outperform traditional classifiers in CHD prediction, offering high accuracy, robustness, and interpretability. These models present a scalable framework for implementing AI-driven diagnostic tools in low-resource environments, potentially transforming early detection and prevention of coronary heart disease.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.